510(k) K201217

HemoCue Hb 301 System by Hemocue AB — Product Code GKR

K201217 is an FDA 510(k) premarket notification submitted by Hemocue AB for the device "HemoCue Hb 301 System". The FDA issued a decision of Substantially Equivalent on August 4, 2020. The device falls under product code GKR (System, Hemoglobin, Automated), a Class II device regulated under 21 CFR 864.5620. Hemocue AB has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
August 4, 2020
Date Received
May 6, 2020
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
System, Hemoglobin, Automated
Device Class
Class II
Regulation Number
864.5620
Review Panel
HE
Submission Type